Adherence to current recommendations on the use of methotrexate in rheumatoid arthritis in Italy: Results from the MARI study

Clinical and Experimental Rheumatology

Volumn 34, Issue 3, 2016, Pages 473-479

  Manara, Maria ^a   Bianchi, Gerolamo ^b   Bruschi, Eleonora ^c   Azzolini, Valeria ^d   Beyene, Nebiat Belai ^e   Corbanese, Stefania ^b   Gennaro, Fabio De ^f   Martin Martin, Luis S ^g   Molica Colella, Aldo B ^h   Pozzi, Maria Rosa ⁱ   Romeo, Nicoletta ^j   Rossini, Tiziana ^k   Severino, Adriana ^l   Sinigaglia, Luigi ^a  

^a ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^b ASL3 Azienda Sanitaria Genovese ^*  (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d Dept of Rheumatology   (Italy)

^e Dept of Rheumatology   (Italy)

^f Centro Emostasi e Trombosi   (Italy)

^g REGINA APOSTOLORUM HOSPITAL   (Italy)

^h Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte   (Italy)

ⁱ UNIVERSITY OF MILANO BICOCCA   (Italy)

^j S CROCE E CARLE HOSPITAL   (Italy)

^k VALDUCE HOSPITAL   (Italy)

^l MAGGIORE HOSPITAL   (Italy)

more..

Author keywords

Methotrexate; Recommendations; Rheumatoid arthritis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN C; FOLIC ACID; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT;

ADULT; ARTICLE; BLOOD CELL COUNT; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DISEASE ACTIVITY; DISEASE DURATION; DRUG SAFETY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; ITALY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCREENING TEST; SUPPLEMENTATION; THORAX RADIOGRAPHY; TREATMENT DURATION; AGED; ARTHRITIS, RHEUMATOID; CLINICAL PRACTICE; CLINICAL TRIAL; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; PRACTICE GUIDELINE; STATISTICS AND NUMERICAL DATA; TIME TO TREATMENT;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; FEMALE; GUIDELINE ADHERENCE; HUMANS; ITALY; MALE; MEDICATION THERAPY MANAGEMENT; METHOTREXATE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; RETROSPECTIVE STUDIES; TIME-TO-TREATMENT;

EID: 84982854486     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. SOKKA T, ENVALDS M, PINCUS T: Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs. Mod Rheumatol 2008; 18: 228-39.
2. SMOLEN JS, LANDEWé R, BREEDVELD FC et al.: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2014; 73: 492-509.
3. VISSER K, KATCHAMART W, LOZA E et al.: Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009; 68: 1086-93.
4. DE LEONARDIS F, ALIVERNINI S, BONACCI E et al.: Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the "3E initiative". Reumatismo 2010; 62: 34-45.
5. TODOERTI M, MAGLIONE W, BERNERO E et al.: Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis. Reumatismo 2013; 65: 207-18.
6. FRANSEN J, LAAN RF, Van Der LAAR MA, HUIZINGA TW, Van RIEL PL: Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis. Ann Rheum Dis 2004; 63: 1222-6.
7. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
8. IDOLAZZI L, ADAMI S, ALTOMONTE L et al.: Suboptimal Methotrexate Use in Rheumatoid Arthritis Patients in Italy: The MARI study. Clin Exp Rheumatol 2015; 33: 895-9.
9. COTTRELL E, CRABTREE V, EDWARDS JJ, RODDY E: Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice. BMC Fam Pract 2013; 14: 170.
10. CURTIS JR, ZHANG J, XIE F et al.: Use of oral and subcutaneous methotrexate in rheumatoid arthritis patients in the United States. Arthritis Car Res 2014; 66: 1604-11.
11. EMERY P, SALMON M: Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 1995; 54: 944-7.
12. HARROLD LR, HARRINGTON JT, CURTIS JR et al.: Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations. Arthritis Rheum 2012; 64: 630-8.
13. VISSER K, van der HEIJDE D: Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature. Ann Rheum Dis 2009; 68: 1094-9.
14. BRAUN J, KASTNER P, FLAXENBERG P et al.: Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial. Arthritis Rheum 2008; 58: 73-81.
15. BINGHAM SJ, BUCH MH, LINDSAY S, POL. LARD A, WHITE J, EMERY P: Parenteral methotrexate should be given before biological therapy. Rheumatology 2003; 42: 1009-10.
16. VISSER K, GOEKOOP-RUITERMAN YP, de VRIES-BOUWSTRA JK et al.: A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study. Ann Rheum Dis 2010; 69: 1333-7.